PATENT CLAIM ANALYSIS

Application Number: 16255769
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "139100"]

Abstract:
Disclosed herein are antibodies specific to a delta1 chain of a γδ T cell receptor and methods of using such for modulating γδ T cell bioactivity. Such anti-Delta1 antibodies may also be used to treat diseases associated with γδ T cell activation, such as solid tumors, or for detecting presence of γδ1 T cells.

Claim (Index 15):
A method of inhibiting the activation of immunosuppressive \u03b3\u03b4 T cell in a subject, the method comprising administering to a subject in need thereof an effective amount of an pharmaceutical composition of  claim 14 .

Metadata:
- Claim Count in Document: 59.0
- Percentile: 99.0
- Lexical Diversity: 1.38095
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16173970', '15271861', '16175453', '15034782', '15712010']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7722415194190843
- 35 USC 102 Novelty (BERT): 0.5482676024836214
- Combined Prediction Score: 0.7498441277255379
- Mean Citation Score: 435.944402
- Max Citation Score: 467.11746
- Similarity Product: 269.8043174128604

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test